Philippines - English - FDA (Food And Drug Administration)

transfarma philippines inc. - dexketoprofen (as trometamol) - tablet, film coated - 25mg

Philippines - English - FDA (Food And Drug Administration)

under license from: menarini international operations luxembourg s.a.; importer: transfarma philippines, inc. - zofenopril calcium - film-coated tablet - 7.5 mg

Philippines - English - FDA (Food And Drug Administration)

under license from: menarini international operations luxembourg s.a.; importer: transfarma philippines, inc. - zofenopril calcium - film-coated tablet - 30 mg

Philippines - English - FDA (Food And Drug Administration)

under license from: menarini international operations luxembourg s.a.; importer: transfarma philippines, inc. - zofenopril calcium - film-coated tablet - 15 mg

United States - English - NLM (National Library of Medicine)

laboratoire aguettant - zinc gluconate trihydrate (unii: f2f0xu34wq) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml

Israel - English - Ministry of Health

medison pharma ltd - ataluren - granules for oral suspension - ataluren 1000 mg - ataluren - translarna is indicated for the treatment of duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older. efficacy has not been demonstrated in non-ambulatory patients. the presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.

Israel - English - Ministry of Health

medison pharma ltd - ataluren - granules for oral suspension - ataluren 125 mg - ataluren - translarna is indicated for the treatment of duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older. efficacy has not been demonstrated in non-ambulatory patients. the presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing

Israel - English - Ministry of Health

medison pharma ltd - ataluren - granules for oral suspension - ataluren 250 mg - ataluren - translarna is indicated for the treatment of duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older. efficacy has not been demonstrated in non-ambulatory patients. the presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.

European Union - English - EMA (European Medicines Agency)

ptc therapeutics international limited - ataluren - muscular dystrophy, duchenne - other drugs for disorders of the musculo-skeletal system - translarna is indicated for the treatment of duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older. efficacy has not been demonstrated in non-ambulatory patients.the presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.

United States - English - NLM (National Library of Medicine)

omp, inc. - octinoxate 7.5% zinc oxide 10.5% - the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. specially formulated for blending purposes as part of the obagi nu-derm system. sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun